Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07056790 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer

Name: Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer — clinical trial record (NCT07056790)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1/2

SponsorFirst Affiliated Hospital of Fujian Medical University

Started2025-05-15

View on ClinicalTrials.gov ↗

First Affiliated Hospital of Fujian Medical University

56 trials monitored

See all monitored trials

Prostate Cancer

2,471 trials monitored

See 156 trials at risk

68Ga-PSMA-CYC is a novel radiotracer targeting PSMA. In this study, we investigated the safety, biodistribution, radiation dosimetry of 68Ga-PSMA-CYC PET/CT in patients with prostate cancer, and performed a head-to-head comparison with 68Ga-PSMA-617 and 68Ga-PSMA-11 to evaluate its diagnostic performance.

Trial Details

NCT Number	NCT07056790
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Prostate CA
Enrollment	40 participants
Start Date	2025-05-15
Primary Completion	2027-02 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2025-07-09